Panita Pathipvanich
Overview
Explore the profile of Panita Pathipvanich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yanagisawa K, Wichukchinda N, Tsuchiya N, Yasunami M, Rojanawiwat A, Tanaka H, et al.
PLoS One
. 2020 Dec;
15(12):e0242438.
PMID: 33362211
Background: Mannose-binding lectin (MBL) plays a pivotal role in innate immunity; however, its impact on susceptibility to opportunistic infections (OIs) has not yet been examined in a natural history cohort...
2.
Wieczorek L, Peachman K, Adams D, Barrows B, Molnar S, Schoen J, et al.
Virology
. 2020 Aug;
548:152-159.
PMID: 32838936
Despite anti-retroviral therapy (ART) interventions for HIV+ pregnant mothers, over 43,000 perinatal infections occur yearly. Understanding risk factors that lead to mother-to-child transmission (MTCT) of HIV are critical. We evaluated...
3.
Liegeon G, Harrison L, Nechba A, Halue G, Banchongkit S, Nilmanat A, et al.
J Infect
. 2019 Aug;
79(5):454-461.
PMID: 31401085
Objectives: The risk of kidney dysfunction on the WHO recommended first line regimens containing tenofovir disoproxil fumarate (TDF) without protease inhibitors (PI) remains unclear in Asian patients, especially those with...
4.
Hiransuthikul A, Trachunthong D, Pattanachaiwit S, Teeratakulpisarn N, Chamnan P, Pathipvanich P, et al.
AIDS Care
. 2019 Feb;
31(9):1178-1183.
PMID: 30747545
The test-and-treat approach has the potential to reduce high-risk sexual behaviors by linking high-risk individuals to health education, although this has not been proven yet. We used longitudinal data from...
5.
Hiransuthikul A, Pattanachaiwit S, Teeratakulpisarn N, Chamnan P, Pathipvanich P, Thongpaen S, et al.
Int J STD AIDS
. 2018 Oct;
30(2):140-146.
PMID: 30296916
We determined subsequent and recurrent sexually transmitted infections (STIs) among men who have sex with men (MSM) and transgender women (TGW) in the Test and Treat cohort. Thai MSM and...
6.
Phanuphak N, Pattanachaiwit S, Pankam T, Teeratakulpisarn N, Chamnan P, Pathipvanich P, et al.
J Int AIDS Soc
. 2018 Sep;
21(9):e25186.
PMID: 30225927
Introduction: Sexually transmitted infections (STIs) are common among HIV-positive men who have sex with men (MSM). There have been concerns that undiagnosed and untreated STIs could undermine efforts to use...
7.
Mori M, Wichukchinda N, Miyahara R, Rojanawiwat A, Pathipvanich P, Miura T, et al.
J Acquir Immune Defic Syndr
. 2018 Mar;
78(3):356-361.
PMID: 29528943
Background: Class I human leukocyte antigen (HLA) molecules contribute to HIV control through antigen presentation to both cytotoxic T lymphocytes and natural killer cells. Contribution of cytotoxic T lymphocytes to...
8.
Gangcuangco L, Sawada I, Tsuchiya N, Do C, Pham T, Rojanawiwat A, et al.
Am J Trop Med Hyg
. 2017 Jul;
97(1):49-56.
PMID: 28719295
To identify regional differences in the distribution of opportunistic infections (OIs) among human immunodeficiency virus (HIV)-infected patients in Asia, the medical records of antiretroviral therapy (ART)-naïve patients who attended the...
9.
Mori M, Wichukchinda N, Miyahara R, Rojanawiwat A, Pathipvanich P, Tsuchiya N, et al.
AIDS
. 2015 Sep;
29(13):1607-15.
PMID: 26372271
Objective: Class I human leukocyte antigen (HLA) alleles interact with both cytotoxic T lymphocytes through their T-cell receptors, and natural killer cells through their killer immunoglobulin-like receptors (KIRs). Compared with...
10.
Tsuchiya N, Pathipvanich P, Wichukchinda N, Rojanawiwat A, Auwanit W, Ariyoshi K, et al.
BMC Infect Dis
. 2014 Nov;
14:565.
PMID: 25361850
Background: Antiretroviral therapy markedly reduced mortality in HIV-infected individuals. However, in the previous studies, up to 50% of patients are compelled to modify their regimen in middle and low-income countries...